Evaluation of 18F-Fluciclovine PET-MRI in LGG
EARLY_PHASE1
30
about 1.8 years
1–21
1 site in PA
What this study is about
This trial is testing if 18F-Fluciclovine (Axumin®) is useful and safe for children with Low Grade Gliomas (LGG). Imaging will be performed before, during, and after treatment to see how changes in 18F-Fluciclovine uptake compare to MRI measurements.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 18F-Fluciclovine
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
fluciclovine (18F)
Primary: Compare changes in pretreatment tumor measurement on MRI in pediatric participants who initiate systemic treatment for LGG
Neurology